Age, Albumin, and LDH Predict Outcome of Patients with Limited Stage Peripheral T Cell Lymphoma: A Prognostic Model Developed on 244 Cases Enrolled in the T Cell Project 1 By the International T Cell Project Network
Greg Hapgood(Princess Alexandra Hospital), Massimo Federico(University of Modena and Reggio Emilia), John Radford(Manchester Academic Health Science Centre), Felicitas Hitz(Kantonsspital St. Gallen), Stefano Luminari(University of Modena and Reggio Emilia), Monica Civallero(University of Modena and Reggio Emilia), Martina Manni(University of Modena and Reggio Emilia), Stefano Pileri(European Institute of Oncology), Francine M. Foss(Yale Cancer Center), Arnon Nagler(Sheba Medical Center), Ranjana H. Advani(Stanford Medicine), Steven M. Horwitz(Memorial Sloan Kettering Cancer Center), María Elena Cabrera(Hospital del Salvador), Julie M. Vose(University of Nebraska Medical Center), Yana Stepanishyna(National Cancer Institute), Judith Trotman(The University of Sydney), Tetiana Skrypets(University of Modena and Reggio Emilia), Carlos Chiattone(Hospital Samaritano de São Paulo), Won-Seog Kim(Samsung Medical Center), Iván Dlouhy
Cited by 0
Related Papers
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune Cells
|New England Journal of Medicine|2004|1.4k